Trial Profile
Efficacy of entecavir in lamivudine-resistant (LAM-R) patients with chronic hepatitis B (CHB): A long term follow-up
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 16 Dec 2015 New trial record